Ovarian teratoma development after anti-NMDA receptor encephalitis treatment

@article{Omata2017OvarianTD,
  title={Ovarian teratoma development after anti-NMDA receptor encephalitis treatment},
  author={Taku Omata and Kazuo Kodama and Yoshimi Watanabe and Yukiko Iida and Yoshiaki Furusawa and Akiko Takashima and Yukitoshi Takahashi and Hiroshi Sakuma and Keiko Tanaka and Katsunori Fujii and Naoki Shimojo},
  journal={Brain and Development},
  year={2017},
  volume={39},
  pages={448-451}
}

Figures from this paper

A refractory anti-NMDA receptor encephalitis successfully treated by bilateral ovariectomy and intrathecal injection of methotrexate and dexamethasone: A case report

For refractory cases of anti-NMDA receptor encephalitis, intrathecal injection of MTX and DXM may be beneficial and more research is required to elucidate the mechanisms of intratheCal treatment.

The Association of Ovarian Teratoma and Anti-N-Methyl-D-Aspartate Receptor Encephalitis: An Updated Integrative Review

This review aims to summarize recent reports on the association between anti-NMDAR encephalitis and ovarian teratoma, and to provide an in-depth review of this issue to better understand its epidemiology, diagnostic approach, and treatment strategies.

Anti-NMDA Receptor Encephalitis Associated with Ovarian Teratoma: Pathophysiology and when to Suspect

It is important to recognize the epidemiology and to be aware of when to suspect about this disease, once early treatment (surgical resection and immunotherapy) is associated with greater prognosis.

A refractory anti-NMDA receptor encephalitis successfully treated by bilateral salpingo-oophorectomy and intrathecal injection of methotrexate and dexamethasone: a case report

Intrathecal injection of MTX and DXM may be beneficial for treatment of refractory cases of anti-NMDA receptor encephalitis.

Postoperative Anti–N-methyl-D-aspartate (NMDA) Receptor Encephalitis After Surgical Resection of Teratom

A case of a 33 year-old female with anti-NMDAR encephalitis that interestingly developed after the surgical resection of ovarian teratoma is reported.

Immune thrombocytopenia in a case of trisomy 18

It is indicated that even children with anti-NMDAR encephalitis can have a comorbid malignancy that progresses later, and not only the initial chemotherapy but also the early second-line therapy might have prevented any the neurological relapses.

Recidiva de teratoma ovárico tras encefalitis anti-NMDA y manejo de la fertilidad: caso clínico.

Before performing repetead ovarian surgeries, oocyte vitrificaction must be considered as a fertility-sparing option in women who have not completed their childbearing wishes and must be suspected when atypical encephalitis occurs.

A metastatic malignancy of unknown primary origin in a 12‐year‐old girl with anti‐N‐methyl‐d‐aspartate encephalitis

The clinical course and renal pathology of the patient suggest that the diagnosis of PIGN is likely instead of MPO-ANCA-mediated GN, and Physicians should be aware of subsequent development of P IGN in cases of prolonged staphylococcal infection even though an attenuated bacterium such as MSSE is still unclear.

Imaging of pediatric ovarian tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.

This paper offers consensus recommendations for imaging of pediatric patients with a known or suspected primary ovarian malignancy at diagnosis and during follow-up.

Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment

Classic ICU complications better serve as prognostic markers than the individual subtype of AE, and mechanical ventilation, sepsis, and autonomic dysregulation appear to indicate longer or incomplete convalescence in patients with AE.

References

SHOWING 1-9 OF 9 REFERENCES

[Clinical evaluation of six patients with anti-NMDAR encephalitis].

OBJECTIVE We examined the clinical course and the prognosis of patients with anti-NMDAR encephalitis. METHODS We retrospectively evaluated the patients who has distinctive clinical features as

Analysis of relapses in anti-NMDAR encephalitis

Relapses in anti-NMDAR encephalitis are common and may occur many years after the initial episode, and immunotherapy at first episode reduces the risk of relapses.

Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients.

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

Detection of autoantibody against extracellular epitopes of N-methyl-d-aspartate receptor by cell-based assay

Anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in children and adolescents

To report the clinical features of anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in patients ≤ 18 years old.

Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratoma

The autoantigens of a new category of treatment‐responsive paraneoplastic encephalitis are reported, and it is proposed that this category should be combined with existing treatment-responsive encephalopathy categories.